These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6256141)

  • 41. Identification and characterization of the rabbit angiotensin II myocardial receptor.
    Baker KM; Campanile CP; Trachte GJ; Peach MJ
    Circ Res; 1984 Mar; 54(3):286-93. PubMed ID: 6321055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies defining minimal receptor domains for angiotensin II.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1989 Jul; 250(1):31-6. PubMed ID: 2746504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin receptor: properties and relevance to the development of antagonists.
    Soffer RL; Kiron MA; Rosenberg E; Bandyopadhyay S
    Kidney Int Suppl; 1988 Oct; 26():S69-72. PubMed ID: 3199686
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of covalent dimer conjugates of angiotensin II on receptor affinity and activity in vitro.
    de Gasparo M; Whitebread S; Kamber B; Criscione L; Thomann H; Riniker B; Andreatta R
    J Recept Res; 1991; 11(1-4):247-57. PubMed ID: 1886081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
    Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
    Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation of renal membranes that contain kallikrein, angiotensin I-converting enzyme (kininase II) and angiotensinase in the rat.
    Ward PE; Erdös EG; Gedney CD; Dowben RM; Reynolds RC
    Clin Sci Mol Med Suppl; 1976 Dec; 3():267s-270s. PubMed ID: 192512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of essential disulfide bonds in angiotensin II binding sites of rabbit hepatic membranes. Inactivation by dithiothreitol.
    Sen I
    Biochim Biophys Acta; 1985 Feb; 813(1):103-10. PubMed ID: 3970913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solubilization of adrenal angiotensin II receptors with a zwitterionic detergent.
    Capponi AM; Birabeau MA; Vallotton MB
    J Recept Res; 1983; 3(1-2):289-99. PubMed ID: 6304304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture.
    Penit J; Faure M; Jard S
    Am J Physiol; 1983 Jan; 244(1):E72-82. PubMed ID: 6295182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demonstration of different contractile mechanisms for angiotensin II and des-Asp1-angiotensin II in rabbit aortic strips.
    Ackerly JA; Moore AF; Peach MJ
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5725-8. PubMed ID: 271997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes.
    Paglin S; Jamieson JD
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3739-43. PubMed ID: 6285362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unexpected binding of an octapeptide to the angiotensin II receptor.
    Soffer RL; Bandyopadhyay S; Rosenberg E; Hoeprich P; Teitelbaum A; Brunck T; Colby CB; Gloff C
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9219-22. PubMed ID: 3480539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin tachyphylaxis and vascular angiotensinase activity.
    Hollenberg NK; Barbero LR; Hinrichs KP
    Experientia; 1971 Sep; 27(9):1032-4. PubMed ID: 4329996
    [No Abstract]   [Full Text] [Related]  

  • 55. The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta.
    Webb ML; Dickinson KE; Delaney CL; Liu EC; Serafino R; Cohen RB; Monshizadegan H; Moreland S
    Biochem Biophys Res Commun; 1992 Jun; 185(3):887-92. PubMed ID: 1320879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor.
    Ojima M; Inada Y; Shibouta Y; Wada T; Sanada T; Kubo K; Nishikawa K
    Eur J Pharmacol; 1997 Jan; 319(1):137-46. PubMed ID: 9030909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific and irreversible block of the myotropic action of angiotensin II.
    Escher EH; Nguyen TM; Guillemette G; Regoli DC
    Nature; 1978 Sep; 275(5676):145-6. PubMed ID: 211425
    [No Abstract]   [Full Text] [Related]  

  • 58. Angiotensin receptors in pulmonary arterial and aortic endothelial cells.
    Patel JM; Yarid FR; Block ER; Raizada MK
    Am J Physiol; 1989 May; 256(5 Pt 1):C987-93. PubMed ID: 2719100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The angiotensin II receptor and the actions of angiotensin II.
    Peach MJ; Dostal DE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S25-30. PubMed ID: 1705624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Control of aldosterone secretion during sodium restriction: adrenal receptor regulation and increased adrenal sensitivity to angiotensin II.
    Aguilera G; Hauger RL; Catt KJ
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):975-9. PubMed ID: 204942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.